These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 32947313)

  • 41. Delphi consensus on stereotactic ablative radiotherapy for oligometastatic and oligoprogressive renal cell carcinoma-a European Society for Radiotherapy and Oncology study endorsed by the European Association of Urology.
    Marvaso G; Jereczek-Fossa BA; Zaffaroni M; Vincini MG; Corrao G; Andratschke N; Balagamwala EH; Bedke J; Blanck O; Capitanio U; Correa RJM; De Meerleer G; Franzese C; Gaeta A; Gandini S; Garibaldi C; Gerszten PC; Gillessen S; Grubb WR; Guckenberger M; Hannan R; Jhaveri PM; Josipovic M; Kerkmeijer LGW; Lehrer EJ; Lindskog M; Louie AV; Nguyen QN; Ost P; Palma DA; Procopio G; Rossi M; Staehler M; Tree AC; Tsang YM; Van As N; Zaorsky NG; Zilli T; Pasquier D; Siva S
    Lancet Oncol; 2024 May; 25(5):e193-e204. PubMed ID: 38697165
    [TBL] [Abstract][Full Text] [Related]  

  • 42. TROG 15.03 phase II clinical trial of Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney - FASTRACK II.
    Siva S; Chesson B; Bressel M; Pryor D; Higgs B; Reynolds HM; Hardcastle N; Montgomery R; Vanneste B; Khoo V; Ruben J; Lau E; Hofman MS; De Abreu Lourenco R; Sridharan S; Brook NR; Martin J; Lawrentschuk N; Kron T; Foroudi F
    BMC Cancer; 2018 Oct; 18(1):1030. PubMed ID: 30352550
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Stereotactic body radiation therapy for primary kidney cancer].
    Abancourt L; Le Guévelou J; Taillez A; Vu A; de Crevoisier R; Supiot S; Hennequin C; Chapet O; Blanchard P; Mirabel X; Lartigau É; Pasquier D
    Cancer Radiother; 2023 Sep; 27(6-7):568-572. PubMed ID: 37543493
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Radiotherapy for renal-cell carcinoma.
    De Meerleer G; Khoo V; Escudier B; Joniau S; Bossi A; Ost P; Briganti A; Fonteyne V; Van Vulpen M; Lumen N; Spahn M; Mareel M
    Lancet Oncol; 2014 Apr; 15(4):e170-7. PubMed ID: 24694640
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Spine Radiosurgery in the Management of Renal Cell Carcinoma Metastases.
    Taunk NK; Spratt DE; Bilsky M; Yamada Y
    J Natl Compr Canc Netw; 2015 Jun; 13(6):801-9; quiz 809. PubMed ID: 26085394
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Oligometastatic non-small cell lung cancer: a narrative review of stereotactic ablative radiotherapy.
    Dohopolski M; Iyengar P
    Ann Palliat Med; 2021 May; 10(5):5944-5953. PubMed ID: 33691460
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Stereotactic body radiation therapy (SBRT) on renal cell carcinoma, an overview of technical aspects, biological rationale and current literature.
    Francolini G; Detti B; Ingrosso G; Desideri I; Becherini C; Carta G; Pezzulla D; Caramia G; Dominici L; Maragna V; Teriaca MA; Bottero M; Livi L
    Crit Rev Oncol Hematol; 2018 Nov; 131():24-29. PubMed ID: 30293702
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of stereotactic body radiotherapy vs palliative radiotherapy on oncologic outcomes of patients with metastatic kidney cancer concomitantly treated with immune checkpoint inhibitors: a preliminary, multicentre experience.
    Francolini G; Campi R; Di Cataldo V; Detti B; Loi M; Triggiani L; La Mattina S; Borghetti P; Magrini SM; Nicosia L; Alongi F; Ghirardelli P; Vavassori V; Allegra AG; Aquilano M; Scoccimarro E; Peruzzi A; Pastina P; Visani L; Desideri I; Serni S; Meattini I; Livi L
    Clin Transl Oncol; 2022 Oct; 24(10):2039-2043. PubMed ID: 35739349
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Global management of brain metastasis from renal cell carcinoma.
    Pierrard J; Tison T; Grisay G; Seront E
    Crit Rev Oncol Hematol; 2022 Mar; 171():103600. PubMed ID: 35063636
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Safety and Efficacy of Stereotactic Ablative Radiation Therapy for Renal Cell Carcinoma Extracranial Metastases.
    Wang CJ; Christie A; Lin MH; Jung M; Weix D; Huelsmann L; Kuhn K; Meyer J; Desai N; Kim DWN; Pedrosa I; Margulis V; Cadeddu J; Sagalowsky A; Gahan J; Laine A; Xie XJ; Choy H; Brugarolas J; Timmerman R; Hannan R
    Int J Radiat Oncol Biol Phys; 2017 May; 98(1):91-100. PubMed ID: 28587057
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Management of oligometastatic and oligoprogressive renal cell carcinoma: state of the art and future directions.
    Donini M; Buti S; Massari F; Mollica V; Rizzo A; Montironi R; Bersanelli M; Santoni M
    Expert Rev Anticancer Ther; 2020 Jun; 20(6):491-501. PubMed ID: 32479120
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A prospective Phase II trial of using extracranial stereotactic radiotherapy in primary and metastatic renal cell carcinoma.
    Svedman C; Sandström P; Pisa P; Blomgren H; Lax I; Kälkner KM; Nilsson S; Wersäll P
    Acta Oncol; 2006; 45(7):870-5. PubMed ID: 16982552
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Radiation therapy in renal cell carcinoma.
    De Felice F; Tombolini V
    Crit Rev Oncol Hematol; 2018 Aug; 128():82-87. PubMed ID: 29958634
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Implementation of a volumetric modulated arc therapy treatment planning solution for kidney and adrenal stereotactic body radiation therapy.
    Sonier M; Chu W; Lalani N; Erler D; Cheung P; Korol R
    Med Dosim; 2016 Winter; 41(4):323-328. PubMed ID: 27745995
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Carbon ion radiation therapy for primary renal cell carcinoma: initial clinical experience.
    Nomiya T; Tsuji H; Hirasawa N; Kato H; Kamada T; Mizoe J; Kishi H; Kamura K; Wada H; Nemoto K; Tsujii H
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):828-33. PubMed ID: 18374507
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [A systematic review of radiotherapy for primary renal cell carcinoma].
    Gladilina IA; Shabanov MA; Kushlinskii NE; Bliganov PI; Sergeev AN
    Urologiia; 2022 Mar; (1):96-101. PubMed ID: 35274868
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Landscape of Stereotactic Ablative Radiotherapy (SABR) for Renal Cell Cancer (RCC).
    Moreno-Olmedo E; Sabharwal A; Das P; Dallas N; Ford D; Perna C; Camilleri P
    Cancers (Basel); 2024 Jul; 16(15):. PubMed ID: 39123406
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Stereotactic ablative radiotherapy for primary kidney cancer.
    Brown N; Breen DJ; Buckley BT; Clements W; Gangi A; Rogan C
    Lancet Oncol; 2024 Jun; 25(6):e229. PubMed ID: 38821090
    [No Abstract]   [Full Text] [Related]  

  • 59. Stereotactic ablative radiotherapy for primary kidney cancer.
    Bhargava P; Jena R; Giri RK
    Lancet Oncol; 2024 Jun; 25(6):e228. PubMed ID: 38821089
    [No Abstract]   [Full Text] [Related]  

  • 60. Stereotactic Ablative Body Radiotherapy for Primary Renal Cell Carcinoma in Non-surgical Candidates: Initial Clinical Experience.
    Chang JH; Cheung P; Erler D; Sonier M; Korol R; Chu W
    Clin Oncol (R Coll Radiol); 2016 Sep; 28(9):e109-14. PubMed ID: 27131756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.